These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 838874)

  • 1. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
    Gollan JL; Stocks J; Dormandy TL; Sherlock S
    J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease.
    Graul RS; Epstein O; Sherlock S; Scheuer PJ
    Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups.
    Gibbs K; Walshe JM
    Q J Med; 1979 Jul; 48(191):447-63. PubMed ID: 396544
    [No Abstract]   [Full Text] [Related]  

  • 7. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
    Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct measurement of serum non-caeruloplasmin copper in liver disease.
    Frommer DJ
    Clin Chim Acta; 1976 May; 68(3):303-7. PubMed ID: 1277546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper distribution among serum proteins in paediatric liver disorders and malignancies.
    Barrow L; Tanner MS
    Eur J Clin Invest; 1988 Dec; 18(6):555-60. PubMed ID: 3147183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and clinical changes in Wilson's disease heterozygotes.
    Marecek Z; Nevsímalová S
    J Inherit Metab Dis; 1984; 7(1):41-5. PubMed ID: 6429441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for diagnosis of Wilson's disease.
    Ryan A; Nevitt SJ; Tuohy O; Cook P
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31743430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome oxidase deficiency in Wilson's disease: a suggested ceruloplasmin function.
    Shokeir MH; Shreffler DC
    Proc Natl Acad Sci U S A; 1969 Mar; 62(3):867-72. PubMed ID: 4308098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Western blot analysis in patients with hypocaeruloplasminaemia.
    Chowrimootoo GF; Andoh J; Seymour CA
    QJM; 1997 Mar; 90(3):197-202. PubMed ID: 9093597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a stable copper isotope (65Cu) in the differential diagnosis of Wilson's disease.
    Lyon TD; Fell GS; Gaffney D; McGaw BA; Russell RI; Park RH; Beattie AD; Curry G; Crofton RJ; Gunn I
    Clin Sci (Lond); 1995 Jun; 88(6):727-32. PubMed ID: 7634759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin.
    Cauza E; Maier-Dobersberger T; Polli C; Kaserer K; Kramer L; Ferenci P
    J Hepatol; 1997 Aug; 27(2):358-62. PubMed ID: 9288611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease.
    Evans PJ; Bomford A; Halliwell B
    Free Radic Res Commun; 1989; 7(1):55-62. PubMed ID: 2806955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caeruloplasmin oxidase activity: measurement in serum by use of o-dianisidine dihydrochloride on a microplate reader.
    Stepien KM; Guy M
    Ann Clin Biochem; 2018 Jan; 55(1):149-157. PubMed ID: 28166667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.